Director, Stanley Ho Centre for Emerging Infections Diseases, School of Public Health & Primary Care, Faculty of Medicine, CUHK
Associate Director (Clinical Liaison), School of Public Health & Primary Care, Faculty of Medicine, CUHK
Chairman & Stanley Ho Professor of Respiratory Medicine, Dept of Medicine & Therapeutics, CUHK.
Director, SH Ho Sleep Apnoea Management Center, Dept of Medicine & Therapeutics, CUHK.
|Tel:||(852) 2632 3128|
|Fax:||(852) 2649 9957|
MBBS (UNSW); MD(UNSW); FRACP; FRCP (Lond, Glasg, Edin); FHKCP; FHKAM
Dr Hui graduated from the University of New South Wales in 1985. He then trained in Respiratory Medicine and Sleep Medicine in Sydney, Australia.
Dr Hui was heavily involved in the clinical management of patients with SARS at the Prince of Wales Hospital during the major outbreak in 2003. He served as a WHO advisor to review the clinical management of influenza A(H5N1) during the early human outbreak in Vietnam in Feb 2004 and has since been a regular advisor to the WHO on the clinical management of severe acute respiratory infections. He joined urgent WHO missions for investigation of outbreaks of MERS in Riyadh and South Korea in 2013 and 2015 respectively. He has contributed to the WHO treatment guidelines including the clinical management of influenza A (H5N1) virus in 2007, clinical management of influenza A (H1N1) pandemic in 2009, and the Middle East Respiratory Syndrome (MERS) and the WHO training workshop in the clinical management of influenza A(H7N9) and COVID-19. He has served as an advisor to the HKSAR government on COVID-19 since Jan 2020.
Dr Hui has published over 360 peer-reviewed journal articles and 24 book chapters since joining the CUHK in 1998. He was the top 1% highly cited researcher (cross fields) in 2021 assessed by Clarivate, with H index of 80, and World's top 2% scientists in 2021 in addition to being ranked second in respiratory medicine (Stanford University, Mendeley Data).
Clinical management of emerging severe acute respiratory infections, the safety of respiratory therapy in the post SARS era, the efficacy of the medical ward airflow in preventing nosocomial infections, sleep disordered breathing, and common airway diseases.